VaccinesEurope
@VaccinesEurope
VE represents major innovative research-based vaccine companies operating in Europe, including SMEs.
VE is a specialised group within EFPIA. #WeWontRest
ID:1262320285
http://www.vaccineseurope.eu 12-03-2013 16:08:10
6,5K Tweets
6,6K Followers
1,0K Following
In Europe, the number of vaccine #clinicaltrials has significantly declined in the last decades - but we can reverse this trend. Find out how Europe can become a hub for vaccine innovation ➡️ bit.ly/3xGkyHo
#ICTD2024 #InternationalClinicalTrialsDay
A new report by Office of Health Economics shows adult immunisation programmes return up to 19 times their initial investment. It is time to see immunisation as a capital investment, not as a cost bit.ly/4b0is3y #VaccinesForLife #WeWontRest
According to Statista, there were over 1.2 billion international tourist arrivals worldwide in 2023. As people continue to travel, new vaccines in development can help people stay safe while abroad #WeWontRest
#HPV #vaccination prevents most cases of cervical #cancer – improving lives, preventing deaths and freeing up vital healthcare resources. Now, let’s #Imagine the next frontier in cancer treatment: vaccines made just for you ➡️ bit.ly/3R2CzFY
#WeWontRest
Despite the significant return on investment that adult immunisation programmes bring, their implementation is lagging behind. Adopting a prevention-first mindset is crucial for building resilient health systems and societies bit.ly/4b0is3y #VaccinesForLife #WeWontRest
In the new EU political mandate, it is crucial to prioritise healthcare, especially immunisation. Increased investment and recognising the value of innovation are key to building resilient healthcare systems across Europe #EUImmunisationStrategy Nicoletta Luppi MSD Europe
Vaccination should be a key element of travel planning. Travellers can encounter a number of health threats that are vaccine-preventable such as rabies and yellow fever. Make sure you're up-to-date with all your vaccinations, including for travel #WeWontRest
#JustPublished !
During 2023 and until April 2024, EU/EEA countries have reported nearly 60 000 cases of #pertussis - a more than 10-fold increase compared to 2022 and 2021.
Rapid Risk Assessment: bit.ly/3WyytK6
Press release: bit.ly/4bjUYGK
In Hungary, there is a significant disparity between vaccination coverage rates for children and older adults. Katalin Szaloki from AIPM calls for an #EUImmunisationStrategy to promote immunisation at all stages of life.
Increasing the accessibility of immunisation programs for #HPV & #HBV helps facilitate uptake & vaccine confidence. Prof Pierre Van Damme, Infectious Disease & Vaccinology Expert at UAntwerpen, shares how expanding vaccination access points can support this ⬇️ #VaccineVoices
Immunisation has curbed or significantly reduced many diseases, making Europe healthier and more prosperous. There is still more we can do to unlock the full potential of immunisation. It is time for an #EUImmunisationStrategy VaccinesEurope 👇️
vaccineseurope.eu/eu-elections-2…
Through #immunisation , the spread of many diseases has been curbed or significantly reduced, making Europe healthier and more prosperous. There is still more we can do to unlock the full potential of immunisation. It is time for an #EUImmunisationStrategy 💪🩺
VaccinesEurope
In the next mandate, Let's support an #EUImmunisationStrategy to help:
📷 Foster more equitable access to immunisation
📷 Improve our readiness to address new public health threats
📷 Ease pressure on our healthcare systems
Through immunisation, the spread of many diseases has been curbed or significantly reduced, making Europe healthier and more prosperous. There is still more we can do to unlock the full potential of immunisation. It is time for an #EUImmunisationStrategy .